New report on Delivra! Hi guys!
DHB posted record revenue for FY2024, up 26% YoY, with Dream Water products leading the charge. Expanded U.S. distribution and new launches, like Sleep Gummies and Immunity Shots, have boosted their footprint. With 74% of sales now coming from international markets, the growth story is shifting beyond Canada.
EBITDA is up 68%, free cash flow turned positive, and gross margins are improving, but SG&A costs kept EPS below estimates. With products already in major chains like Walmart, Kroger, and Shoppers Drug Mart, and upcoming catalysts like U.S. expansion for LivRelief, there’s a lot to consider here.